Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Neovastat (AE-941): Began Phase III testing

Aeterna Laboratories Inc. (TSE:AEL), Quebec City, Quebec
Product: Neovastat

Read the full 94 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE